from FOX News https://ift.tt/2UWQ2Tw
Eli Lilly pharmaceutical company starts Phase 3 coronavirus trial with drug used to treat arthritis
The first patient has been enrolled in Eli Lilly’s Phase 3 clinical trial to test whether an arthritis drug, baricitinib, marketed as Olumiant, can treat hospitalized COVID-19 patients.
from FOX News https://ift.tt/2UWQ2Tw
from FOX News https://ift.tt/2UWQ2Tw
Related Posts:
New study suggests ditching BMI for 'roundness'-based system- How southern European nations will be among the highest life expectancies worldwide
- 8 top health stories of the past week that you need to know now
- Ohio woman with epilepsy finds safety with her service dog: ‘Our bond is set in stone’
- Experts weigh in on the benefits, risks of using castor oil for weight loss
0 comments:
Post a Comment